MedTech Acquisition Corporation Unit
MTACU
MTACU was delisted on the 10th of August, 2023.
6 hedge funds and large institutions have $444K invested in MedTech Acquisition Corporation Unit in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 4 → 6 (+2)
5% more capital invested
Capital invested by funds: $424K → $444K (+$20K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$7.13K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$10 |
Top Sellers
MTACU Hedge Fund Activity: Q3 2022 in Review
6 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in MedTech Acquisition Corporation Unit (MTACU) for Q3 2022, worth a combined $444K — up 4.7% from $424K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MTACU positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Clear Street, opening a new position worth an estimated $7.13K.
- 6 institutional investors held MedTech Acquisition Corporation Unit (MTACU) as of Q3 2022, up from 4 in Q2 2022.
- Funds reported $444K of MedTech Acquisition Corporation Unit stock for Q3 2022, up 4.7% quarter-over-quarter.
- 2 funds opened new MedTech Acquisition Corporation Unit positions in Q3 2022 and 0 closed out, a net change of +2 holders.
- The largest MedTech Acquisition Corporation Unit buyer in Q3 2022 was Clear Street, an estimated $7.13K added.
Based on aggregated 13F filings for Q3 2022.